SCHEMBL9208969

SCHEMBL9208969

CCOC(=O)C(=O)CC(=O)c1ccc(C(C)=O)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.57
▸ POLB P06746 1/20 0.57
▸ SMN1; SMN2 Q16637 1/20 0.57
▸ HDAC3 O15379 2/20 0.43
▸ HDAC4 P56524 2/20 0.43
▸ HDAC1 Q13547 2/20 0.43
▸ HDAC7 Q8WUI4 2/20 0.43
▸ HDAC2 Q92769 2/20 0.43
▸ HDAC10 Q969S8 2/20 0.43
▸ HDAC11 Q96DB2 2/20 0.43
▸ HDAC8 Q9BY41 2/20 0.43
▸ HDAC6 Q9UBN7 2/20 0.43
▸ HDAC9 Q9UKV0 2/20 0.43
▸ HDAC5 Q9UQL6 2/20 0.43
▸ KMT2A Q03164 3/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HPGD P15428 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2911004 0.88 ALDH1A1 (0.58) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL12020298 0.86 ESR1 (0.58) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL25011313 0.85 ALDH1A1 (0.56) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL1686217 0.85 ERCC5 (0.59) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL1694519 0.85 ALDH1A1 (0.56) ALDH1A1POLBSMN1; SMN2HDAC3HDAC4
SCHEMBL1739390 0.85 ALDH1A1 (0.56) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL2916273 0.85 ALDH1A1 (0.56) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL70968 0.84 ERCC5 (0.58) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL9349345 0.83 ERCC5 (0.57) ALDH1A1POLBSMN1; SMN2KMT2ARAB9A
SCHEMBL1694652 0.83 HDAC3 (0.57) ALDH1A1POLBSMN1; SMN2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3246317-B1 BTK INHIBITOR HUBEI BIO PHARMACEUTICAL INDUSTRIAL TECH INSTITUTE INC (CN) 2023-02-22 — — EP disclosed
EP-3246317-A1 BTK INHIBITOR Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. (CN) 2017-11-22 — — EP disclosed
CN-1046506-C Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1999-11-17 — — CN disclosed
EP-0418845-B1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1995-08-09 — — EP disclosed
US-5134142-A PYRAZOLE DERIVATIVES, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-07-28 — — US disclosed
CN-1050382-A Pyrazole derivatives and preparation method thereof and medicinal compositions FUJISAWA PHARMACEUTICAL CO (JP) 1991-04-03 — — CN disclosed
EP-0418845-A1 Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-03-27 — — EP disclosed
Send feedback